Sarepta Therapeutics, Inc. (BVMF:S1RP34)
4.680
-0.150 (-3.11%)
At close: Feb 9, 2026
-85.34% (1Y)
| Market Cap | 9.96B -84.8% |
| Revenue (ttm) | 12.86B +47.1% |
| Net Income | -1.45B |
| EPS | -14.77 |
| Shares Out | n/a |
| PE Ratio | n/a |
| Forward PE | 10.25 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 2,400 |
| Average Volume | 3,378 |
| Open | 4.660 |
| Previous Close | 4.830 |
| Day's Range | 4.650 - 4.730 |
| 52-Week Range | 2.880 - 35.250 |
| Beta | 0.39 |
| RSI | 35.31 |
| Earnings Date | Feb 25, 2026 |